132
Participants
Start Date
September 1, 2010
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
carvedilol
Carvedilol will be administered orally at a start dose of 3.125 mg twice daily. After 1 week, this will increased if systolic blood pressure does not fall below 90 mm Hg. The patient will receive the maximum tolerated dose of carvedilol with a maximum of 6.25 BD.
Placebo
The placebo tablets will be identical to the carvedilol tablets. First the patients will receive placebo in the dose of 1 BD. Then depending on his tolerance it will be increased to a maximum of 2 BD.
RECRUITING
Institute of Liver & Biliary Sciences (ILBS), New Delhi
Institute of Liver and Biliary Sciences, India
OTHER